Session

IBD (Posters)

DIFFUSION-WEIGHTED MAGNETIC RESONANCE ENTEROCOLONOGRAPHY AND CDEIS IN ASSESSING CROHN´S DISEASE ACTIVITY
DIFFUSION-WEIGHTED MAGNETIC RESONANCE ENTEROCOLONOGRAPHY AND CDEIS IN ASSESSING CROHN´S DISEASE ACTIVITY

IBD (Posters)  et al.

EFFICACY OF USTEKINUMAB AT THE END OF MAINTENANCE IN ULCERATIVE COLITIS PATIENTS RECEIVING 6 MG/ KG INDUCTION POSOLOGY. DATA FROM UNIFI TRIAL
EFFICACY OF USTEKINUMAB AT THE END OF MAINTENANCE IN ULCERATIVE COLITIS PATIENTS RECEIVING 6 MG/ KG INDUCTION POSOLOGY. DATA FROM UNIFI TRIAL

IBD (Posters)  et al.

ULCERATIVE COLITIS: CHARACTERISTICS OF INTESTINAL MICROBIOTA IN RUSSIAN POPULATION
ULCERATIVE COLITIS: CHARACTERISTICS OF INTESTINAL MICROBIOTA IN RUSSIAN POPULATION

IBD (Posters)  et al.

TRANSCRIPTIONAL CHANGES AFTER BUDESONIDE TREATMENT IN COLLAGENOUS COLITIS PATIENTS
TRANSCRIPTIONAL CHANGES AFTER BUDESONIDE TREATMENT IN COLLAGENOUS COLITIS PATIENTS

IBD (Posters)  et al.

METHOD COMPARISON STUDY OF TWO COMMERCIALLY AVAILABLE TDM TEST FOR THE MEASUREMENT OF USTEKINUMAB LEVELS
METHOD COMPARISON STUDY OF TWO COMMERCIALLY AVAILABLE TDM TEST FOR THE MEASUREMENT OF USTEKINUMAB LEVELS

IBD (Posters)  et al.

RESPONSE TO INDUCTION TREATMENT WITH BIOLOGICALS IN A MULTICENTER, PROSPECTIVE COHORT OF BIOLOGICAL-NAïVE IBD PATIENTS - PRELIMINARY RESULTS FROM THE DANISH IBD BIOBANK PROJECT
RESPONSE TO INDUCTION TREATMENT WITH BIOLOGICALS IN A MULTICENTER, PROSPECTIVE COHORT OF BIOLOGICAL-NAïVE IBD PATIENTS - PRELIMINARY RESULTS FROM THE DANISH IBD BIOBANK PROJECT

IBD (Posters)  et al.

TREATMENT OF ADULTS WITH THE CLOSTRIDIA STRAIN LIVE BIOTHERAPEUTIC PRODUCT VE202 RESULTS IN SUSTAINED AND DURABLE COLONIZATION OF THE HEALTHY HUMAN GUT
TREATMENT OF ADULTS WITH THE CLOSTRIDIA STRAIN LIVE BIOTHERAPEUTIC PRODUCT VE202 RESULTS IN SUSTAINED AND DURABLE COLONIZATION OF THE HEALTHY HUMAN GUT

IBD (Posters)  et al.

COMPARATIVE BIOAVAILABILITY OF NOVEL CYCLOSPORINE FORMULATIONS VERSUS REFERENCE ORAL CYCLOSPORINE IN HEALTHY SUBJECTS UNDER FASTING CONDITIONS
COMPARATIVE BIOAVAILABILITY OF NOVEL CYCLOSPORINE FORMULATIONS VERSUS REFERENCE ORAL CYCLOSPORINE IN HEALTHY SUBJECTS UNDER FASTING CONDITIONS

IBD (Posters)  et al.

MESALAZINE INDUCES EARLY HISTO-ENDOSCOPIC MUCOSAL HEALING IN ACTIVE MILD-MODERATE ULCERATIVE COLITIS: POST-HOC ANALYSIS OF POOLED DATA FROM 4 DOUBLE-BLIND, DOUBLE-DUMMY, MULTICENTER, RANDOMIZED TRIALS
MESALAZINE INDUCES EARLY HISTO-ENDOSCOPIC MUCOSAL HEALING IN ACTIVE MILD-MODERATE ULCERATIVE COLITIS: POST-HOC ANALYSIS OF POOLED DATA FROM 4 DOUBLE-BLIND, DOUBLE-DUMMY, MULTICENTER, RANDOMIZED TRIALS

IBD (Posters)  et al.

THE VARIABILITY IN THE DISTRIBUTION OF HISTOLOGICAL ACTIVITY IN COLONIC SEGMENTS IN PATIENTS WITH ULCERATIVE COLITIS AND THE IMPACT HEREOF ON THE DEVELOPMENT OF AI TOOLS
THE VARIABILITY IN THE DISTRIBUTION OF HISTOLOGICAL ACTIVITY IN COLONIC SEGMENTS IN PATIENTS WITH ULCERATIVE COLITIS AND THE IMPACT HEREOF ON THE DEVELOPMENT OF AI TOOLS

IBD (Posters)  et al.

THIOPURINE THERAPY IN PAEDIATRIC INFLAMMATORY BOWEL DISEASE: ADVERSE EVENTS AND THIOPURINE METABOLITES
THIOPURINE THERAPY IN PAEDIATRIC INFLAMMATORY BOWEL DISEASE: ADVERSE EVENTS AND THIOPURINE METABOLITES

IBD (Posters)  et al.

EXCLUSIVE ENTERAL NUTRITION OR PREDNISOLONE INDUCTION TREATMENT: CLINICAL AND ENDOSCOPIC EVALUATION OF NEW-ONSET LUMINAL PAEDIATRIC CROHN'S DISEASE
EXCLUSIVE ENTERAL NUTRITION OR PREDNISOLONE INDUCTION TREATMENT: CLINICAL AND ENDOSCOPIC EVALUATION OF NEW-ONSET LUMINAL PAEDIATRIC CROHN'S DISEASE

IBD (Posters)  et al.

COLORECTAL CANCER RISK IN INFLAMMATORY BOWEL DISEASE PATIENTS WITH HIGH-GRADE DYSPLASIA: A SYSTEMATIC REVIEW AND META-ANALYSIS
COLORECTAL CANCER RISK IN INFLAMMATORY BOWEL DISEASE PATIENTS WITH HIGH-GRADE DYSPLASIA: A SYSTEMATIC REVIEW AND META-ANALYSIS

IBD (Posters)  et al.

AZATHIOPRINE AND ANTI-TNF THERAPIES AFFECT THE GUT MICROBIOME DIFFERENTLY IN IBD PATIENTS
AZATHIOPRINE AND ANTI-TNF THERAPIES AFFECT THE GUT MICROBIOME DIFFERENTLY IN IBD PATIENTS

IBD (Posters)  et al.

WNT1-INDUCIBLE SIGNALING PROTEIN-1 IS ASSOCIATED WITH INTESTINAL FIBROSIS IN CROHN´S DISEASE
WNT1-INDUCIBLE SIGNALING PROTEIN-1 IS ASSOCIATED WITH INTESTINAL FIBROSIS IN CROHN´S DISEASE

IBD (Posters)  et al.

POSTOPERATIVE PROPHYLACTIC THIOPURINES OR BIOLOGICALS ARE PROTECTIVE FOR CLINICAL AND ENDOSCOPIC RECURRENCE AT SHORT TERM FOLLOW-UP AFTER PRIMARY ILEOCECAL RESECTION IN CROHN'S DISEASE, BUT NOT ASSOCIATED WITH A LONG-TERM BENEFICIAL EFFECT ON THE RISK OF
POSTOPERATIVE PROPHYLACTIC THIOPURINES OR BIOLOGICALS ARE PROTECTIVE FOR CLINICAL AND ENDOSCOPIC RECURRENCE AT SHORT TERM FOLLOW-UP AFTER PRIMARY ILEOCECAL RESECTION IN CROHN'S DISEASE, BUT NOT ASSOCIATED WITH A LONG-TERM BENEFICIAL EFFECT ON THE RISK OF

IBD (Posters)  et al.

ASSESSMENT OF COMORBIDITY AND PHYSICAL CAPACITY AS MARKERS FOR SAFETY OUTCOMES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
ASSESSMENT OF COMORBIDITY AND PHYSICAL CAPACITY AS MARKERS FOR SAFETY OUTCOMES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

IBD (Posters)  et al.

TIME TRENDS FOR POSTOPERATIVE RECURRENCE AFTER ILEOCECAL RESECTION IN CROHN'S DISEASE: DETAILED EVALUATION OF ASSOCIATED FACTORS
TIME TRENDS FOR POSTOPERATIVE RECURRENCE AFTER ILEOCECAL RESECTION IN CROHN'S DISEASE: DETAILED EVALUATION OF ASSOCIATED FACTORS

IBD (Posters)  et al.

CORRELATION BETWEEN MICROBIAL MARKERS AND FAECAL CALPROTECTIN IN IBD PATIENTS
CORRELATION BETWEEN MICROBIAL MARKERS AND FAECAL CALPROTECTIN IN IBD PATIENTS

IBD (Posters)  et al.

Item 261 - 279 / 279
1 2 3 4 5 6 7 8 9 10 11 12 13
14